Skip to main content
Erschienen in: AIDS and Behavior 1/2013

01.01.2013 | Original Paper

MACH14: A Multi-Site Collaboration on ART Adherence Among 14 Institutions

verfasst von: Honghu Liu, Ira B. Wilson, Kathy Goggin, Nancy Reynolds, Jane M. Simoni, Carol E. Golin, Marc I. Rosen, Robert Gross, Glenn Wagner, Robert H. Remien, Neil Schneiderman, Judith A. Erlen, Julia H. Arnsten, David R. Bangsberg

Erschienen in: AIDS and Behavior | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

The integration of original data from multiple antiretroviral (ARV) adherence studies offers a promising, but little used method to generate evidence to advance the field. This paper provides an overview of the design and implementation of MACH14, a collaborative, multi-site study in which a large data system has been created for integrated analyses by pooling original data from 16 longitudinal ARV adherence studies. Studies selected met specific criteria including similar research design and data domains such as adherence measured with medication event monitoring system, psychosocial factors related to adherence behavior, and virologic and clinical outcomes. The data system created contains individual data (collected between 1997 and 2009) from 2,860 HIV patients. Collaboration helped resolve the challenges inherent in pooling data across multiple studies, yet produced a data system with strong statistical power and potentially greater capacity to address key scientific questions than possible with single-sample studies or even meta-analytic designs.
Literatur
1.
Zurück zum Zitat Feeney ER, Mallon PWG. HIV and HAART-associated dyslipidemia. Open Cardiovasc Med J. 2011;5:49–63.PubMedCrossRef Feeney ER, Mallon PWG. HIV and HAART-associated dyslipidemia. Open Cardiovasc Med J. 2011;5:49–63.PubMedCrossRef
2.
Zurück zum Zitat Enanoria WTA, Ng C, Saha SR, Colford JM Jr. Treatment outcomes after highly active antiretroviral therapy: a meta-analysis of randomised controlled trials. Lancet Infect Dis. 2004;4(7):414–25.PubMedCrossRef Enanoria WTA, Ng C, Saha SR, Colford JM Jr. Treatment outcomes after highly active antiretroviral therapy: a meta-analysis of randomised controlled trials. Lancet Infect Dis. 2004;4(7):414–25.PubMedCrossRef
3.
Zurück zum Zitat Bhaskaran K, Hamouda O, Sannes M, et al. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA. 2008;300(1):51–9.PubMedCrossRef Bhaskaran K, Hamouda O, Sannes M, et al. Changes in the risk of death after HIV seroconversion compared with mortality in the general population. JAMA. 2008;300(1):51–9.PubMedCrossRef
4.
Zurück zum Zitat Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357–66.PubMedCrossRef Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357–66.PubMedCrossRef
5.
Zurück zum Zitat Lucas GM. Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven. J Antimicrob Chemother. 2005;55(4):413–6.PubMedCrossRef Lucas GM. Antiretroviral adherence, drug resistance, viral fitness and HIV disease progression: a tangled web is woven. J Antimicrob Chemother. 2005;55(4):413–6.PubMedCrossRef
6.
Zurück zum Zitat Chen LF, Hoy J, Lewin SR. Ten years of highly active antiretroviral therapy for HIV infection. Med J Aust. 2007;186(3):146–51.PubMed Chen LF, Hoy J, Lewin SR. Ten years of highly active antiretroviral therapy for HIV infection. Med J Aust. 2007;186(3):146–51.PubMed
7.
Zurück zum Zitat Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134(10):968–77.PubMed Liu H, Golin CE, Miller LG, et al. A comparison study of multiple measures of adherence to HIV protease inhibitors. Ann Intern Med. 2001;134(10):968–77.PubMed
8.
Zurück zum Zitat Reynolds NR. Adherence to antiretroviral therapies: state of the science. Curr HIV Res. 2004;2(3):207–14.PubMedCrossRef Reynolds NR. Adherence to antiretroviral therapies: state of the science. Curr HIV Res. 2004;2(3):207–14.PubMedCrossRef
9.
Zurück zum Zitat Pearson CR, Simoni JM, Hoff P, Kurth AE, Martin DP. Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues. AIDS Behav. 2007;11(2):161–73.PubMedCrossRef Pearson CR, Simoni JM, Hoff P, Kurth AE, Martin DP. Assessing antiretroviral adherence via electronic drug monitoring and self-report: an examination of key methodological issues. AIDS Behav. 2007;11(2):161–73.PubMedCrossRef
10.
Zurück zum Zitat Wagner GJ. Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. AIDS Patient Care STD. 2002;16(12):599–608.CrossRef Wagner GJ. Predictors of antiretroviral adherence as measured by self-report, electronic monitoring, and medication diaries. AIDS Patient Care STD. 2002;16(12):599–608.CrossRef
11.
Zurück zum Zitat Wagner G. Placebo practice trials: the best predictor of adherence readiness for HAART among drug users? HIV Clinical Trials. 2003;4(4):269–81.PubMedCrossRef Wagner G. Placebo practice trials: the best predictor of adherence readiness for HAART among drug users? HIV Clinical Trials. 2003;4(4):269–81.PubMedCrossRef
12.
Zurück zum Zitat Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S79–87.PubMedCrossRef Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S79–87.PubMedCrossRef
13.
Zurück zum Zitat Levine AJ, Hinkin CH, Marion S, et al. Adherence to antiretroviral medications in HIV: differences in data collected via self-report and electronic monitoring. Health Psychol. 2006;25(3):329–35.PubMedCrossRef Levine AJ, Hinkin CH, Marion S, et al. Adherence to antiretroviral medications in HIV: differences in data collected via self-report and electronic monitoring. Health Psychol. 2006;25(3):329–35.PubMedCrossRef
14.
Zurück zum Zitat Nachega JB, Hislop M, Dowdy DW, et al. Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults. AIDS. 2008;22(16):2117–25.PubMedCrossRef Nachega JB, Hislop M, Dowdy DW, et al. Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults. AIDS. 2008;22(16):2117–25.PubMedCrossRef
15.
Zurück zum Zitat Rivet Amico K, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. JAIDS J Acq Immune Defic Syndr. 2006;41(3):285–297. Rivet Amico K, Harman JJ, Johnson BT. Efficacy of antiretroviral therapy adherence interventions: a research synthesis of trials, 1996 to 2004. JAIDS J Acq Immune Defic Syndr. 2006;41(3):285–297.
16.
Zurück zum Zitat Konkle-Parker DJ, Erlen JA, Dubbert PM. Lessons learned from an HIV adherence pilot study in the Deep South. Patient Educ Couns. 2010;78(1):91–6.PubMedCrossRef Konkle-Parker DJ, Erlen JA, Dubbert PM. Lessons learned from an HIV adherence pilot study in the Deep South. Patient Educ Couns. 2010;78(1):91–6.PubMedCrossRef
17.
Zurück zum Zitat Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5(2):74–9.PubMedCrossRef Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004;5(2):74–9.PubMedCrossRef
18.
Zurück zum Zitat Pinheiro JC, Bates DM. Mixed-effects models in S and S-PLUS. New York: Springer; 2009. Pinheiro JC, Bates DM. Mixed-effects models in S and S-PLUS. New York: Springer; 2009.
19.
Zurück zum Zitat Teramukai S, Matsuyama Y, Mizuno S, Sakamoto J. Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect. Jpn J Clin Oncol. 2004;34(12):717–21.PubMedCrossRef Teramukai S, Matsuyama Y, Mizuno S, Sakamoto J. Individual patient-level and study-level meta-analysis for investigating modifiers of treatment effect. Jpn J Clin Oncol. 2004;34(12):717–21.PubMedCrossRef
20.
Zurück zum Zitat Jones AP, Riley RD, Williamson PR, Whitehead A. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials. Clin Trials. 2009;6(1):16.PubMedCrossRef Jones AP, Riley RD, Williamson PR, Whitehead A. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials. Clin Trials. 2009;6(1):16.PubMedCrossRef
21.
Zurück zum Zitat Lambert PC, Sutton AJ, Abrams KR, Jones DR. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol. 2002;55(1):86–94.PubMedCrossRef Lambert PC, Sutton AJ, Abrams KR, Jones DR. A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol. 2002;55(1):86–94.PubMedCrossRef
22.
Zurück zum Zitat Cooper H, Patall EA. The relative benefits of meta-analysis conducted with individual participant data versus aggregated data. Psychol Methods. 2009;14(2):165–76.PubMedCrossRef Cooper H, Patall EA. The relative benefits of meta-analysis conducted with individual participant data versus aggregated data. Psychol Methods. 2009;14(2):165–76.PubMedCrossRef
23.
Zurück zum Zitat Liu H, Miller LG, Hays RD, et al. A practical method to calibrate self-reported adherence to antiretroviral therapy. JAIDS J Acq Immune Defic Syndr. 2006;43:S104–12.CrossRef Liu H, Miller LG, Hays RD, et al. A practical method to calibrate self-reported adherence to antiretroviral therapy. JAIDS J Acq Immune Defic Syndr. 2006;43:S104–12.CrossRef
24.
Zurück zum Zitat Liu H, Miller LG, Hays RD, et al. Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. JAIDS J Acq Immune Defic Syndr. 2006;41(3):315–22.CrossRef Liu H, Miller LG, Hays RD, et al. Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity, and other factors. JAIDS J Acq Immune Defic Syndr. 2006;41(3):315–22.CrossRef
25.
Zurück zum Zitat Little RJA, Rubin DB. Statistical analysis with missing data. 2nd ed. New York: Wiley-Interscience; 2002. Little RJA, Rubin DB. Statistical analysis with missing data. 2nd ed. New York: Wiley-Interscience; 2002.
26.
Zurück zum Zitat Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002;7(2):147–77.PubMedCrossRef Schafer JL, Graham JW. Missing data: our view of the state of the art. Psychol Methods. 2002;7(2):147–77.PubMedCrossRef
27.
Zurück zum Zitat Collins LM, Schafer JL, Kam CM. A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychol Methods. 2001;6(4):330–51.PubMedCrossRef Collins LM, Schafer JL, Kam CM. A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychol Methods. 2001;6(4):330–51.PubMedCrossRef
28.
Zurück zum Zitat Newgard CD, Haukoos JS. Advanced statistics: missing data in clinical research—part 2: multiple imputation. Acad Emerg Med. 2007;14(7):669–78.PubMed Newgard CD, Haukoos JS. Advanced statistics: missing data in clinical research—part 2: multiple imputation. Acad Emerg Med. 2007;14(7):669–78.PubMed
Metadaten
Titel
MACH14: A Multi-Site Collaboration on ART Adherence Among 14 Institutions
verfasst von
Honghu Liu
Ira B. Wilson
Kathy Goggin
Nancy Reynolds
Jane M. Simoni
Carol E. Golin
Marc I. Rosen
Robert Gross
Glenn Wagner
Robert H. Remien
Neil Schneiderman
Judith A. Erlen
Julia H. Arnsten
David R. Bangsberg
Publikationsdatum
01.01.2013
Verlag
Springer US
Erschienen in
AIDS and Behavior / Ausgabe 1/2013
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-012-0272-4

Weitere Artikel der Ausgabe 1/2013

AIDS and Behavior 1/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.